GreyOrange is a global technology company headquartered in Singapore with operations throughout the United States, Europe, and Asia. While primarily recognized as a leader in warehouse automation and robotic systems, the company has strategically expanded into healthcare applications including patient monitoring, digital health solutions, and movement disorder management[1].
Founded in 2011, GreyOrange has raised over $300 million in funding and operates as a private company. The company employs over 1,000 people globally and has established itself as a major player in the industrial robotics space. More recently, GreyOrange has applied its expertise in artificial intelligence, sensor technology, and IoT platforms to healthcare, particularly for neurodegenerative disease monitoring and management.
| Attribute | Details |
|---|---|
| Founded | 2011 |
| Headquarters | Singapore |
| CEO | Samay Kohli |
| Founders | Samay Kohli, Ajay S. Khanna |
| Total Funding | $300M+ |
| Employees | 1,000+ |
| Operations | US, Europe, Asia |
| Status | Private |
GreyOrange was founded in 2011 with a focus on robotics and automation for logistics:
2011: Company founded by Samay Kohli and Ajay S. Khanna at IIT Delhi
2013: Launched first warehouse robotic system in India
2015: Expanded operations to US and Europe
2017: Raised $100M Series C funding
2018: Became one of the top warehouse automation providers globally
Recognizing the applicability of their technology to healthcare:
2019: Launched healthcare division focused on patient monitoring
2020: Developed movement disorder monitoring platform
2021: Partnered with hospitals for clinical validation
2022: Expanded to Parkinson's disease applications
2023: Added digital health platform capabilities
2024: Continued healthcare growth alongside core logistics business
GreyOrange is a leading provider of warehouse automation solutions:
Products:
Market Position:
The healthcare division applies core technology to medical applications[2]:
Focus Areas:
Target Conditions:
GreyOrange has developed specialized solutions for Parkinson's disease monitoring and management:
Body-Worn Sensors:
Capabilities:
AI-Powered Analytics:
Integration Features:
GreyOrange has partnered with healthcare institutions to validate their technology:
Assessment Metrics:
Clinical Applications:
GreyOrange's healthcare solutions leverage their established technology infrastructure:
| Technology | Healthcare Application |
|---|---|
| ML/AI Algorithms | Movement pattern analysis, symptom classification |
| IoT Sensors | Wearable devices, environmental monitors |
| Cloud Analytics | Real-time data processing, trend analysis |
| Robotics | Rehabilitation assistance, physical therapy |
Wearable Devices:
Environmental Sensors:
Patient-Facing:
Clinician-Facing:
GreyOrange's healthcare strategy focuses on:
Advantages:
Challenges:
The global Parkinson's disease monitoring market is growing rapidly:
Market Drivers:
Estimated Market Size:
| Company | Focus | Product Type |
|---|---|---|
| Abbott | Neuromodulation | Implantable devices |
| Verily | Wearables | Sensor platforms |
| Verily/Samsung | Monitoring | Digital platforms |
| GreyOrange | Wearables, AI | Movement analysis |
| Year | Round | Amount | Lead Investors |
|---|---|---|---|
| 2015 | Series A | $30M | Blume Ventures |
| 2017 | Series B | $30M | Accel Partners |
| 2017 | Series C | $100M | Tiger Global, others |
| 2019 | Series D | $140M | Mithril Capital |